Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 1, 2008, Pages 85-91

  Mangoni, Maria Luisa ^b   Maisetta, Giuseppantonio ^a   Di Luca, Mariagrazia ^a   Gaddi, Ludovica Marcellini Hercolani ^b   Esin, Semih ^a   Florio, Walter ^a   Brancatisano, Franca Lisa ^a   Barra, Donatella ^b   Campa, Mario ^a   Batoni, Giovanna ^a  

^a UNIVERSITY OF PISA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBININ H2; ESCULENTIN 1B[1-18]; POLYPEPTIDE ANTIBIOTIC AGENT; TEMPORIN A; TEMPORIN B; TEMPORIN G; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; AMPHIBIA; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; ENTEROCOCCUS FAECIUM; FROG; HOSPITAL INFECTION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERUM; SKIN; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

AMINO ACID SEQUENCE; AMPHIBIAN PROTEINS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANURA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PROTEINS; RANIDAE;

EID: 37849011149     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00796-07     Document Type: Article

References (40)

1. Alanis, A. J. 2005. Resistance to antibiotics: are we in the post-antibiotic era? Arch. Med. Res. 36:697-705.
2. Batoni, G., G. Maisetta, S. Esin, and M. Campa. 2006. Human beta-defensin-3: a promising antimicrobial peptide. Mini Rev. Med. Chem. 6:1063-1073.
3. Boman, H. G. 1995. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13:61-92.
4. Boman, H. G. 2000. Innate immunity and the normal microflora. Immunol. Rev. 173:5-16.
5. Chen, Q., D. Wade, K. Kurosaka, Z. Y. Wang, J. J. Oppenheim, and D. Yang. 2004. Temporin A and related frog antimicrobial peptides use formyl peptide receptor-like 1 as a receptor to chemoattract phagocytes. J. Immunol. 173:2652-2659.
6. Cirioni, O., A. Giacometti, R. Ghiselli, W. Kamysz, F. Orlando, F. Mocchegiani, C. Silvestri, A. Licci, J. Lukasiak, V. Saba, and G. Scalise. 2005. Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. J. Infect. Dis. 192:1613-1620.
7. Conlon, J. M., J. Kolodziejek, and N. Nowotny. 2004. Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim. Biophys. Acta 1696:1-14.
8. Gales, A. C., R. N. Jones, K. R. Forward, J. Linares, H. S. Sader, and J. Verhoef. 2001. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin. Infect. Dis. 32:S104-S113.
9. Giacometti, A., O. Cirioni, R. Ghiselli, F. Mocchegiani, F. Orlando, C. Silvestri, A. Bozzi, A. Di Giulio, C. Luzi, M. L. Mangoni, D. Barra, V. Saba, G. Scalise, and A. C. Rinaldi. 2006. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. Antimicrob. Agents Chemother. 50:2478-2486.
10. Hancock, R. E., and R. Lehrer. 1998. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:82-88.
11. Harjunpaa, I., P. Kuusela, M. T. Smoluch, J. Silberring, H. Lankinen, and D. Wade. 1999. Comparison of synthesis and antibacterial activity of temporin A. FEBS Lett. 449:187-190.
12. Heymann, D. L. 2006. Resistance to anti-infective drugs and the threat to public health. Cell 124:671-675.
13. Koczulla, A. R., and R. Bals. 2003. Antimicrobial peptides: current status and therapeutic potential. Drugs 63:389-406.
14. Kraus, D., and A. Peschel. 2006. Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr. Top. Microbiol. Immunol. 306:231-250.
15. Maisetta, G., G. Batoni, S. Esin, W. Florio, D. Bottai, F. Favilli, and M. Campa. 2006. In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. Antimicrob. Agents Chemother. 50:806-809.
16. Mangoni, M. L., D. Fiocco, G. Mignogna, D. Barra, and M. Simmaco. 2003. Functional characterisation of the 1-18 fragment of esculentin-1b, an antimicrobial peptide from Rana esculenta. Peptides 24:1771-1777.
17. Mangoni, M. L., N. Papo, J. M. Saugar, D. Barra, Y. Shai, M. Simmaco, and L. Rivas. 2006. Effect of natural L- to D-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H. Biochemistry 45:4266-4276.
18. Mangoni, M. L., A. C. Rinaldi, A. Di Giulio, G. Mignogna, A. Bozzi, D. Barra, and M. Simmaco. 2000. Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur. J. Biochem. 267:1447-1454.
19. Mangoni, M. L., J. M. Saugar, M. Dellisanti, D. Barra, M. Simmaco, and L. Rivas. 2005. Temporins, small antimicrobial peptides with leishmanicidal activity. J. Biol. Chem. 280:984-990.
20. Mangoni, M. L. 2006. Temporins, anti-infective peptides with expanding properties. Cell. Mol. Life Sci. 63:1060-1069.
21. Mangoni, M. L., N. Grovale, A. Giorgi, G. Mignogna, M. Simmaco, and D. Barra. 2000. Structure-function relationships in bombinins H, antimicrobial peptides from Bombina skin secretions. Peptides 21:1673-1679.
22. Mangoni, M. L., R. Miele, T. G. Renda, D. Barra, and M. Simmaco. 2001. The synthesis of antimicrobial peptides in the skin of Rana esculenta is stimulated by microorganisms. FASEB J. 15:1431-1432.
23. Mangoni, M. L., A. C. Rinaldi, A. Di Giulio, G. Mignogna, A. Bozzi, D. Barra, and M. Simmaco. 2000. Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur. J. Biochem. 267:1147-1154.
24. Marr, A. K., W. J. Gooderham, and R. E. Hancock. 2006. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6:468-472.
25. Mignogna, G., M. Simmaco, G. Kreil, and D. Barra. 1993. Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata. EMBO J. 12:4829-4832.
26. Nicolas, P., and A. Mor. 1995. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 49:277-304.
27. Peschel, A., and H. G. Sahl. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
28. Reddy, K. V., R. D. Yedery, and C. Aranha. 2004. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents 24:536-547.
29. Rosenfeld, Y., D. Barra, M. Simmaco, Y. Shai, and M. L. Mangoni. 2006. A synergism between temporins toward gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer. J. Biol. Chem. 281:28565-28574.
30. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
31. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248.
32. Simmaco, M., G. Mignogna, D. Barra, and F. Bossa. 1993. Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta. FEBS Lett. 324:159-161.
33. Simmaco, M., G. Mignogna, S. Canofeni, R. Miele, M. L. Mangoni, and D. Barra. 1996. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur. J. Biochem. 242:788-792.
34. Simmaco, M., D. Barra, F. Chiarini, L. Noviello, P. Melchiorri, G. Kreil, and K. Richter. 1991. A family of bombinin-related peptides from the skin of Bombina variegata. Eur. J. Biochem. 199:217-222.
35. Simmaco, M., G. Mignogna, D. Barra, and F. Bossa. 1994. Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides. J. Biol. Chem. 269:11956-11961.
36. Wade, D., J. Silberring, R. Soliymani, S. Heikkinen, I. Kilpelainen, H. Lankinen, and P. Kuusela. 2000. Antibacterial activities of temporin A analogs. FEBS Lett. 479:6-9.
37. Yeaman, M. R., K. D. Gank, A. S. Bayer, and E. P. Brass. 2002. Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices. Antimicrob. Agents Chemother. 46:3883-3891.
38. Yoshikawa, T. T. 2002. Antimicrobial resistance and aging: beginning of the end of the antibiotic era? J. Am. Geriatr. Soc. 50:S226-S229.
39. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
40. Zhang, L., J. Parente, S. M. Harris, D. E. Woods, R. E. Hancock, and T. J. Falla. 2005. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob. Agents Chemother. 49:2921-2927.